Clinical Trials on Refractory Colorectal Carcinoma in Japan
Total 960 results
-
Hamamatsu UniversityCompletedEsophageal Cancer | Squamous Cell CarcinomaJapan
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma | Recurrent Nasopharyngeal Undifferentiated Carcinoma | Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 | Adult Nasal Type Extranodal NK/T-Cell Lymphoma | Stage IV Nasopharyngeal Undifferentiated Carcinoma...United States, Singapore, Japan, Hong Kong
-
Daiichi Sankyo Co., Ltd.CompletedCervical Cancer | Small Cell Lung Cancer | Ovarian Cancer | Non-small Cell Lung Cancer | Gastric Cancer (Inoperable and Recurrent)Japan
-
Otsuka Pharmaceutical Co., Ltd.Active, not recruitingRelapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)Japan
-
Astellas Pharma IncSeagen Inc.CompletedMetastatic Urothelial CancerJapan
-
Novartis PharmaceuticalsActive, not recruitingRenal Cell Carcinoma | Colorectal Cancer | Gastroesophageal CancerUnited Kingdom, Australia, Belgium, Germany, Italy, Taiwan, Czechia, Israel, Spain, Japan, Singapore, Canada, Korea, Republic of, United States, Chile
-
PfizerTerminatedGastric Cancer | Non Small Cell Lung Cancer | Advanced Solid Tumors | Gastroesophageal Junction Cancer | Urothelial Cancer | Head and Neck Squamous Cell CarcinomasUnited States, Japan
-
SanofiRegeneron PharmaceuticalsCompletedColorectal Cancer MetastaticJapan
-
Kanazawa UniversityUnknownNon-Small-Cell Lung CarcinomaJapan
-
AstraZenecaIonis Pharmaceuticals, Inc.CompletedAdvanced Adult Hepatocellular Carcinoma | Hepatocellular Carcinoma MetastaticKorea, Republic of, Taiwan, Hong Kong, Japan
-
Bristol-Myers SquibbCompleted
-
Boehringer IngelheimCompleted
-
Onconova Therapeutics, Inc.TerminatedMyelodysplastic Syndrome | MDS | Refractory Anemia With Excess Blasts | RAEBUnited States, Spain, Canada, France, Australia, Switzerland, Israel, Japan, Belgium, India, Ireland, United Kingdom, Croatia, Czechia, Poland, Estonia, Germany, Italy, Austria, Hungary, Russian Federation, Sweden
-
Bristol-Myers SquibbCompleted
-
Novartis PharmaceuticalsRecruitingCarcinoma, Non-Small-Cell Lung | Lung Cancer | Neoplasms, Lung | Pulmonary Neoplasms | Neoplasms, Pulmonary | Pulmonary Cancer | Cancer of Lung | Cancer of the Lung | KRAS G12C Mutant Solid Tumors | Carcinoma, ColorectalUnited States, Japan, Australia, Germany, Italy, Spain, Canada, Denmark, Korea, Republic of, Taiwan, Belgium, Hong Kong, China, France, Singapore, Netherlands
-
Genzyme, a Sanofi CompanyCompleted
-
GAIA BioMedicine Inc.Recruiting
-
Chiba UniversityCompleted
-
BayerCompletedThyroid CarcinomaJapan
-
Mitsubishi Tanabe Pharma CorporationCompletedKawasaki Disease Refractory to Initial Therapy With Intravenous ImmunoglobulinJapan
-
Eli Lilly and CompanyCompletedUrologic Neoplasms | Carcinoma, Transitional CellJapan
-
Boehringer IngelheimRecruitingHead and Neck Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Gastrointestinal Cancer | Liver CancerJapan
-
Japanese Gynecologic Oncology GroupCompletedFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CancerJapan
-
SanofiRegeneron PharmaceuticalsCompletedColorectal Cancer MetastaticTaiwan, China, Hong Kong, Japan, Singapore
-
Chugai PharmaceuticalRecruitingHepatocellular Carcinoma (HCC)Taiwan, Japan
-
Novartis PharmaceuticalsCompletedMedulloblastoma | Basal Cell Carcinoma | Advanced Solid Tumor CancersTaiwan, Hong Kong, Japan
-
AmgenActive, not recruitingRelapsed/Refractory Small Cell Lung CancerUnited States, Belgium, Italy, Spain, Portugal, Austria, Greece, Korea, Republic of, Denmark, Netherlands, Germany, France, Taiwan, Japan, United Kingdom, Poland, Switzerland, Singapore
-
PfizerTerminatedMetastatic Colorectal CancerKorea, Republic of, United States, Japan, Spain
-
Spectrum Pharmaceuticals, IncTerminated
-
Japan Multinational Trial OrganizationCompleted
-
Akita University HospitalHuman Genome Center, Institute of Medical Science, University of TokyoSuspendedBile Duct CancerJapan
-
junya mitaCompleted
-
AstraZenecaWithdrawnCancer | Non Small Cell Lung Cancer | Epithelial Ovarian CancerJapan
-
Otsuka Pharmaceutical Co., Ltd.Completed
-
Boehringer IngelheimRecruitingNeuroendocrine Neoplasms | Small Cell Lung Carcinoma (SCLC)Germany, Belgium, Japan, France
-
PfizerNo longer availableNeoplasms | Carcinoma, Non-Small-Cell LungJapan
-
Janssen Research & Development, LLCCompletedNeoplasms | Lymphoma | Adenocarcinoma | Esophagogastric JunctionJapan
-
AbbVieRecruitingColorectal Cancer | Non-Small Cell Lung Cancer | Advanced Solid Tumors | Gastroesophageal AdenocarcinomaUnited States, Japan, Puerto Rico, Taiwan, Spain, Australia, France, Israel, Korea, Republic of, Poland
-
Chiba UniversityCompletedPancreatic Cancer | Bile Duct CancerJapan
-
Boehringer IngelheimTerminatedCarcinoma, Non-Small-Cell LungJapan
-
Boehringer IngelheimCompletedCarcinoma, HepatocellularJapan
-
Yakult Honsha Co., LTDCompletedHepatocellular CarcinomaJapan, Korea, Republic of
-
National Cancer Center Hospital EastDaiichi Sankyo Co., Ltd.RecruitingGastric Adenocarcinoma | Gastroesophageal Junction AdenocarcinomaJapan
-
AstraZenecaCompletedNon-Small Cell Lung Cancer | Advanced Solid Malignancies | Neoplasms, | Metastatic Cancer,Japan
-
Zeria PharmaceuticalCompletedMetastatic Pancreatic AdenocarcinomaJapan, Korea, Republic of, Taiwan
-
Eisai Co., Ltd.Ono Pharmaceutical Co. LtdCompletedCarcinoma, HepatocellularJapan
-
Olympus CorporationMayo Clinic; The University of Texas Health Science Center, Houston; Kyushu UniversityCompleted
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
Masahiro TsuboiEli Lilly and Company; Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer Stage II | Non-small Cell Lung Cancer Stage IB | Non-small Cell Lung Cancer Stage ⅢAJapan
-
Millennium Pharmaceuticals, Inc.TerminatedSmall Cell Lung Cancer | Ovarian Cancer | Advanced Solid TumorsJapan, Korea, Republic of